Claudin18.2-targeted CAR-T Therapy
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Claudin18.2-targeted CAR-T Therapy, covering 2025-12-05 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Clinical Study of Claudin18.2-Targeted Activated DC and CAR-T Therapy in Advanced Pancreatic Cancer. [EARLY_Phase 1]